<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04675216</url>
  </required_header>
  <id_info>
    <org_study_id>19/07/2017</org_study_id>
    <nct_id>NCT04675216</nct_id>
  </id_info>
  <brief_title>Posterior Fossa Intracranial Pressure (ICP) Measurement: Clinical Study</brief_title>
  <acronym>Postfossa ICP</acronym>
  <official_title>Posterior Fossa Intracranial Pressure (ICP) Measurement in Cases of Traumatic, Ischemic, or Tumor Pathology (Post-surgical) at This Level: Clinical Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Valencia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Valencia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In modern medicine, doctors attempt to monitor all physiological variables to assess their&#xD;
      evolution and to decide, based on their changes, the therapeutic attitudes to adopt.&#xD;
      Furthermore, this helps to establish a forecast of the evolution to be expected.&#xD;
&#xD;
      The measurement of Intracranial Pressure (ICP) has become indispensable for managing brain&#xD;
      pathology at the anterior and middle fossa level. Doctors generally carry out this&#xD;
      measurement at the frontal level. However, experimental and clinical studies have shown that&#xD;
      supra-tentorial ICP measurement does not precisely predict the ICP situation in the posterior&#xD;
      fossa.&#xD;
&#xD;
      The increased ICP in the posterior fossa is directly responsible for the clinical&#xD;
      deterioration and eventual death in patients with tumour, hemorrhagic, or ischemic pathology&#xD;
      of the posterior fossa structures. Some of these lesions are treatable, and their effects&#xD;
      reversible if the increase in ICP in the posterior fossa is controlled by pharmacological or&#xD;
      even surgical means, preventing it from reaching high levels. This need for on-time ICP&#xD;
      control is genuine in the cerebellar hemispheres' lesions, not so much in lesions involving&#xD;
      the brainstem. Therefore, the increase in ICP in the posterior fossa needs to be known and&#xD;
      documented to facilitate decision-making regarding the therapy to be adopted, be it medical&#xD;
      or surgical.&#xD;
&#xD;
      It is known what the abnormal ICP levels are at the supratentorial level, but what is not&#xD;
      known whether these same levels apply to the posterior fossa. In other words, what it is not&#xD;
      know with certainty is whether the same levels of ICP in the posterior fossa and its&#xD;
      elevation during the same time are going to have equally pernicious effects or these effects&#xD;
      are greater or lesser. Doctors need to have tables of ICP values in the posterior fossa to&#xD;
      help them decide when these values are in the physiological range. When posterior fossa&#xD;
      intracranial pressure lye in the pathological range, and patients need pharmacological&#xD;
      treatment or surgical decompression, knowing for sure the posterior fossa ICP is essential.&#xD;
      Finally, when doctors also need to know when any therapeutic attempt is useless.&#xD;
&#xD;
      Currently, doctors only monitor the ICP at the supra-tentorial level and deduce the changes&#xD;
      in the posterior fossa from the CT and MRI images, that is, the size of the lesions, the&#xD;
      occlusion of the cisterns, the internal cerebral hernias (cerebellar tonsils, trans-tentorial&#xD;
      hernia from bottom to top). However, doctors do not have a tool that can objectify the&#xD;
      pathophysiological situation of the posterior fossa's structures in real-time.&#xD;
&#xD;
      Monitoring the posterior fossa ICP will help doctors in decision-making in patients with&#xD;
      traumatic, hemorrhagic, ischemic, or tumour pathologies (in the latter case, in the&#xD;
      postoperative period of posterior fossa tumours). This posterior fossa ICP measurement will&#xD;
      lead to improvements in morbidity/mortality in this subgroup of patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of our study is to register the posterior fossa pressure in normal postoperative&#xD;
      conditions and in patients with different kinds of posterior fossa pathologies. The aim of&#xD;
      the study is to get a range of posterior fossa intracranial pressure values in physiological&#xD;
      situations and then to get the same data in patients with posterior fossa pathologies. The&#xD;
      ideal would be to monitor the posterior fossa ICP in normal subjects but this is something&#xD;
      that does not seem ethically correct. That is why, instead, the posterior fossa ICP will be&#xD;
      measured in posterior fossa post-operative time. These patients will have to be operated any&#xD;
      way for their posterior fossa pathologies, and adding a posterior fossa ICP sensor does not&#xD;
      seem a problem from the ethical point of view. In any case, patients will be asked to sign&#xD;
      informed consent. The second aim of our study will be to compare the supratentorial (frontal&#xD;
      area) ICP monitoring with the posterior fossa ICP monitoring to see if their values coincide&#xD;
      or if there are deviations. This will help doctors to decide when posterior fossa ICP must be&#xD;
      done and not to rely only on supratentorial (frontal) ICP monitoring.&#xD;
&#xD;
        1. A study will be done on 12 patients. The series published to date are very short.&#xD;
&#xD;
        2. Inclusion criteria: age 18 years, traumatic pathology, tumour, ischemic or hemorrhagic&#xD;
           posterior fossa, GCS 8 or lower.&#xD;
&#xD;
        3. EXCLUSION CRITERIA coagulation disorders, fault multi-organic, multiple pathologies,&#xD;
           head trauma open posterior fossa with output nerve tissue.&#xD;
&#xD;
        4. Inserting PIC level sensor above-tentorial (1 sensor PIC) and another level&#xD;
           infra-tentorial (2nd sensor PIC).&#xD;
&#xD;
        5. Verification that the ICP sensor in the posterior fossa can be implanted at the same&#xD;
           point as we implanted it in cadavers without more significant clinical repercussions&#xD;
           than those seen with the insertion of the ICP at the supra-tentorial level. In that&#xD;
           sense, we have to confirm the technique's safety at the selected point away from the&#xD;
           lateral sinus and sigmoid sinus and the lateral part of the occipital shell. We must&#xD;
           also verify that it is not incredibly annoying for patients (in any case, it will be&#xD;
           patients in a coma and probably sedated), but it is about confirming that the movements&#xD;
           of the patients do not cause problems in the ICP sensor of the posterior fossa and if&#xD;
           they do will be sought (in collaboration with the manufacturer) technical amendments&#xD;
           necessary to avoid any problems that go detecting&#xD;
&#xD;
        6. Data Collection ICP level supra and infra-tentorial. These data will be recorded&#xD;
           continuously on a computer for later analysis.&#xD;
&#xD;
        7. Data analysis ICP supra and infra-tentorial comparing the figures obtained in the two&#xD;
           compartments (the supra and infra-tentorial).&#xD;
&#xD;
        8. Analysis of the correlation or non-correlation between the supra-tentorial ICP and&#xD;
           infra-tentorial ICP figures.&#xD;
&#xD;
        9. Correlating data PIC infra-tentorial with the clinical status of patients and their&#xD;
           evolution.&#xD;
&#xD;
       10. Analysis of possible complications attributable to the inclusion of the ICP monitor&#xD;
           posterior fossa, analyzing possible areas for improvement to minimize any possible risk.&#xD;
           In particular, we will analyze the risk of bruising-hematoma in the cerebellar&#xD;
           hemisphere at the insertion point.&#xD;
&#xD;
       11. Analysis of therapeutic decisions based on figures from the PIC in the posterior fossa.&#xD;
&#xD;
       12. Analysis of the results and their correlation with therapeutic attitudes adopted.&#xD;
&#xD;
       13. Preparation of recommendations.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 19, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Posterior fossa intracranial pressure</measure>
    <time_frame>1 month</time_frame>
    <description>We will measure the posterior fossa intracranial pressure inserting a ICP sensor at the frontal area and another at the posterior fossa 2cm behind and at the level of the tip of mastoid process. The ICP values will be measured while patients are in ICU and for 2 days once back in the neurosurgical ward</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical status of patients</measure>
    <time_frame>1 month</time_frame>
    <description>We will correlate the clinical status of each patient with his/her posterior fossa intracranial pressure. The clinical status will include the Glasgow Coma Scale and the Glasgow Coma Score</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Intracranial Pressure Increase</condition>
  <arm_group>
    <arm_group_label>Posterior fossa lesion</arm_group_label>
    <description>This group will be integrated by patients with posterior fossa lesion that likely to rise the posterior fossa intracranial pressure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Post-operative posterior fosa surgical patients</arm_group_label>
    <description>This group will be integrated by patients operated for posterior fossa lesions in which we will try to find out what range of posterior fossa pressure is to be expected in this situation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Posterior fossa intracranial pressure measurement</intervention_name>
    <description>Measurement of posterior fossa pressure in an invasive way</description>
    <arm_group_label>Post-operative posterior fosa surgical patients</arm_group_label>
    <arm_group_label>Posterior fossa lesion</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with posterior fossa lesions, traumatic, neoplastic, ischemic, or hemorrhagic&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  minimum age of 18 years&#xD;
&#xD;
          -  traumatic, tumor, ischemic, or hemorrhagic pathology of the posterior fossa&#xD;
&#xD;
          -  GCS of 8 or less.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  coagulation disorders&#xD;
&#xD;
          -  multi-organ failure&#xD;
&#xD;
          -  multiple pathologies&#xD;
&#xD;
          -  open head trauma to the posterior fossa with leakage of nervous tissue&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital General Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vicente Vanaclocha, MDPhD</last_name>
      <phone>+34 963 13 18 00</phone>
      <phone_ext>438500</phone_ext>
      <email>vivava@uv.es; vvanaclo@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Teresa Moratal</last_name>
      <phone>+34 963 13 18 00</phone>
      <phone_ext>437334</phone_ext>
      <email>ceicvalencia_hgv@gva.es</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Vicente Vanaclocha</name>
      <address>
        <city>Valencia</city>
        <zip>46015</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vicente Vanaclocha Vanaclocha, Prof MD PhD</last_name>
      <phone>669790013</phone>
      <email>vvanaclo@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Vicente Vanaclocha Vanaclocha</last_name>
      <phone>669790013</phone>
      <email>vvanaclo@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <results_reference>
    <citation>Mizunari T. [Clinical aspects and intracranial pressure monitoring in cases of traumatic posterior fossa hematoma]. Nihon Ika Daigaku Zasshi. 1990 Aug;57(4):334-43. Japanese.</citation>
    <PMID>2229331</PMID>
  </results_reference>
  <results_reference>
    <citation>Oshorov AV, Savin IA, Goriachev AS, Popugaev KA, Lubnin AIu. [Monitoring of intracranial pressure difference between supra- and infratentorial spaces after posterior fossa tumor removal (case report)]. Anesteziol Reanimatol. 2011 Jul-Aug;(4):74-7. Russian.</citation>
    <PMID>21957628</PMID>
  </results_reference>
  <results_reference>
    <citation>Rosenwasser RH, Kleiner LI, Krzeminski JP, Buchheit WA. Intracranial pressure monitoring in the posterior fossa: a preliminary report. J Neurosurg. 1989 Oct;71(4):503-5.</citation>
    <PMID>2795169</PMID>
  </results_reference>
  <results_reference>
    <citation>Rieger A, Rainov NG, Sanchin L, Ebel H, Furka I, Görömbey Z, Burkert W. Is it useful to measure supratentorial ICP in the presence of a posterior fossa lesion? Absence of transtentorial pressure gradients in an animal model. Br J Neurosurg. 1999 Oct;13(5):454-8.</citation>
    <PMID>10627774</PMID>
  </results_reference>
  <results_reference>
    <citation>Rooker S, De Visscher G, Van Deuren B, Borgers M, Jorens PG, Reneman RS, van Rossem K, Verlooy J. Comparison of intracranial pressure measured in the cerebral cortex and the cerebellum of the rat. J Neurosci Methods. 2002 Sep 15;119(1):83-8.</citation>
    <PMID>12234639</PMID>
  </results_reference>
  <results_reference>
    <citation>Park CK. Accuracy of ICP monitoring in posterior fossa lesions. J Neurosurg. 1990 May;72(5):832-3.</citation>
    <PMID>2324809</PMID>
  </results_reference>
  <results_reference>
    <citation>Slavin KV, Misra M. Infratentorial intracranial pressure monitoring in neurosurgical intensive care unit. Neurol Res. 2003 Dec;25(8):880-4.</citation>
    <PMID>14669535</PMID>
  </results_reference>
  <results_reference>
    <citation>Wolfla CE, Luerssen TG, Bowman RM, Putty TK. Brain tissue pressure gradients created by expanding frontal epidural mass lesion. J Neurosurg. 1996 Apr;84(4):642-7.</citation>
    <PMID>8613857</PMID>
  </results_reference>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 14, 2020</study_first_submitted>
  <study_first_submitted_qc>December 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 19, 2020</study_first_posted>
  <last_update_submitted>December 21, 2020</last_update_submitted>
  <last_update_submitted_qc>December 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intracranial pressure</keyword>
  <keyword>Posterior fossa</keyword>
  <keyword>Posterior fossa tumor</keyword>
  <keyword>Cerebellar hematoma</keyword>
  <keyword>Cerebellar infarct</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intracranial Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>To collect all the data and publish them</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

